Active, Not Recruiting
A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)
NCT06891066
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Zuckerberg San Francisco General Hospital and Trauma Center ( Site 4107) San Francisco, California, United States
- Mills Clinical Research ( Site 4109) West Hollywood, California, United States
- Georgetown University Medical Center ( Site 4106) Washington D.C., District of Columbia, United States
- Orlando Immunology Center ( Site 4103) Orlando, Florida, United States